These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1751676)

  • 1. Immunoadsorption with PH-350: as a beneficial therapy for acute Guillain-Barre syndrome.
    Ishida H; Shimizu Y; Imada K; Itagaki T; Urushidani Y; Shimoyama R; Oono Y
    Biomater Artif Cells Immobilization Biotechnol; 1991; 19(1):267-75. PubMed ID: 1751676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Double filtration and immunoadsorption plasmapheresis in Guillain-Barré syndrome].
    Kuwabara S; Nakajima M; Moroo I; Hirayama K
    Rinsho Shinkeigaku; 1996 Feb; 36(2):289-92. PubMed ID: 8752682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmapheresis and acute Guillain-Barré syndrome. The Guillain-Barré syndrome Study Group.
    Neurology; 1985 Aug; 35(8):1096-104. PubMed ID: 4022342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasmapheresis and hormone therapy in severe forms of Guillain-Barré syndrome].
    Levchenko NI; Piradov MA; Pirogov VN
    Klin Med (Mosk); 1989 Dec; 67(12):88-91. PubMed ID: 2560799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of Guillain-Barré syndrome. A comparison between steroid and plasmapheresis.
    Cocito D; Durelli L; Bergamini L
    Acta Neurol (Napoli); 1986 Apr; 8(2):129-36. PubMed ID: 3716897
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of Guillain-barre syndrome: immunoglobulins or plasmapheresis?].
    Martínez Yélamos A; Huerta Villanueva M; Olivé Plana M; Montero Homs J; Serra Catafau J; Martínez-Matos JA
    Neurologia; 1998 Apr; 13(4):166-9. PubMed ID: 9608755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effects of plasmapheresis in acute Guillain-Barré syndrome.
    Piccolo G; Cosi V; Lombardi M; Poloni M; Ceroni M; Fornasari PM
    Ital J Neurol Sci; 1986 Jun; 7(3):349-52. PubMed ID: 3733414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and neurophysiologic study of Guillain Barré syndrome: results of therapy with plasmapheresis].
    Fasanaro AM; Pizza V; Florio C; Tancredi G; Fabbri P; Aiello L; Viscidi E; Rossi V; Vacca C
    Riv Neurol; 1991; 61(1):39-45. PubMed ID: 1857922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasmapheresis and high-dose immunoglobulins in the treatment of acute demyelinating polyneuropathy].
    Marino A; Logi G; Roncucci P; Sodini ML; Fornaini F
    Minerva Anestesiol; 1993 Jun; 59(6):307-11. PubMed ID: 8414090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe Guillain-Barré syndrome in aged patients: the effect of plasmapheresis.
    Yamashita S; Morinaga T; Matsumoto K; Sakamoto T; Kaku N; Matsukura S
    Intern Med; 1992 Nov; 31(11):1313-6. PubMed ID: 1295631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guillain-Barré syndrome in childhood. Characteristic course and therapeutic possibilities].
    Korinthenberg R; Sauer M
    Monatsschr Kinderheilkd; 1992 Nov; 140(11):792-8. PubMed ID: 1335122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of therapeutic plasmapheresis in the acute Guillain-Barré syndrome.
    McKhann GM; Griffin JW; Cornblath DR; Quaskey SA; Mellits ED
    J Neuroimmunol; 1988 Dec; 20(2-3):297-300. PubMed ID: 3198752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of the efficacy of plasma exchange, immunoadsorption plasmapheresis and corticosteroid administration in the treatment of Guillain-Barré syndrome].
    Yamazaki M; Koh CS; Hanyu N; Sakai T; Inoue A; Yanagisawa N
    Arerugi; 1995 Apr; 44(4):498-502. PubMed ID: 7598643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of plasmapheresis in childhood Guillain-Barré syndrome.
    Epstein MA; Sladky JT
    Ann Neurol; 1990 Jul; 28(1):65-9. PubMed ID: 2375635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two cases of severe Guillain-Barré syndrome refractory to double-filtration plasmapheresis but responsive to plasma exchange with fresh frozen plasma (FFP).
    Sasaki N; Ando Y; Tabei K; Kusano E; Yoshida M; Asano Y
    J Clin Apher; 1996; 11(3):165-7. PubMed ID: 8915822
    [No Abstract]   [Full Text] [Related]  

  • 16. Liquorpheresis (CSF-filtration): an effective treatment in acute and chronic severe autoimmune polyradiculoneuritis (Guillain-Barré syndrome).
    Wollinsky KH; Weindler M; Hülser PJ; Geiger P; Matzek N; Mehrkens HH; Kornhuber HH
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(2):73-6. PubMed ID: 1834187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Removal ability of immunoglobulins in plasma exchange and double-filtration plasmapheresis].
    Tagawa Y; Yuki N
    Rinsho Shinkeigaku; 1997 May; 37(5):410-2. PubMed ID: 9294330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of the Guillain-Barré syndrome by plasmapheresis.
    Osterman PO; Fagius J; Säfwenberg J; Danersund A; Wallin BG; Nordesjö LO
    Arch Neurol; 1982 Mar; 39(3):148-54. PubMed ID: 7065932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasmapheresis therapy in Guillain-Barré polyneuroradiculitis].
    Zwahlen H; Quadri F; Mombelli G; Tatti V; Marone C
    Schweiz Med Wochenschr; 1988 Dec; 118(49):1854-8. PubMed ID: 3217776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmapheresis in the treatment of the Guillain-Barré syndrome in childhood.
    Yoshioka M; Kuroki S; Mizue H
    Pediatr Neurol; 1985; 1(6):329-34. PubMed ID: 2854736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.